Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

Published:2018-08-03 Issue:1 Volume:10 Page:
ISSN:1868-7075
Container-title:Clinical Epigenetics
language:en
Short-container-title:Clin Epigenet

Author:

Ahlén Bergman Emma^ORCID,Hartana Ciputra Adijaya,Johansson Markus,Linton Ludvig B.,Berglund Sofia,Hyllienmark Martin,Lundgren Christian,Holmström Benny,Palmqvist Karin,Hansson Johan,Alamdari Farhood,Huge Ylva,Aljabery Firas,Riklund Katrine,Winerdal Malin E.,Krantz David,Zirakzadeh A. Ali,Marits Per,Sjöholm Louise K.,Sherif Amir,Winqvist Ola

Funder

Cancerfonden

Knut och Alice Wallenbergs Stiftelse

Vetenskapsrådet

Regionala forskningsrådet i Uppsala-Örebroregionen (RFR in Uppsala-Örebro)

Vetenskapsrådet funding for clinical research in medicine (ALF) in Västerbotten

Västerbotten Läns Landsting

Cancer Research Foundation in Northern Sweden (SE)

Stiftelsen Emil Anderssons fond för Medicinsk forskning

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Developmental Biology,Genetics,Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13148-018-0536-6.pdf

Reference33 articles.

1. Malats N, Real FX. Epidemiology of bladder cancer. Hematol Oncol Clin North Am. 2015;29(2):177–89, vii.

2. Torre LA, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

3. Burger M, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2013;63(2):234–41.

4. Murta-Nascimento C, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol. 2007;25(3):285–95.

5. Kawai K, et al. Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine. Cancer Sci. 2013;104(1):22–7.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of response to neoadjuvant therapy in urothelial cancer;Critical Reviews in Oncology/Hematology;2024-02

2. Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer;Frontiers in Genetics;2022-12-02

3. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma;Frontiers in Cell and Developmental Biology;2022-08-23

4. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma;Frontiers in Medicine;2022-07-07

5. Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma;Cancers;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3